PD-1/PD-L1 Inhibitors Pipeline Surges with 41 Molecules, 12% Bispecifics Fueling Innovation | DataM Intelligence
As per DataM Intelligence, there are 41 unique PD-1/PD-L1 pipeline molecules, 12% are bispecific, highlighting a major expansion in immunotherapy innovation. TEXAS, TX, UNITED STATES, August 12, 2025 /EINPresswire.com/ -- PD-1/PD-L1 …